A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

NCT01101906 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped Company decided not to pursue the development of this drug in this patient population at this time

Conditions

Interventions

Sponsor

Astellas Pharma Inc